HROW

Recent stories

• +8

  Harrow's portfolio showcased in key scientific presentations.

  1 source·30/09, 11:12·finviz.com

• +7

  Harrow, Inc. acquires Melt Pharmaceuticals, enhancing growth potential.

  1 source·18/11, 13:02·sec.gov

• 0

  10-Q form submitted!

  1 source·10/11, 22:18·sec.gov

• +5

  Harrow, Inc. announces financial results and updates.

  1 source·10/11, 22:10·sec.gov

• -2

  CEO transition at ImprimisRx effective October 6, 2025.

  1 source·06/10, 11:26·sec.gov

• +5

  Harrow announces merger with Melt Pharmaceuticals.

  1 source·01/10, 11:40·sec.gov

• +3

  New credit agreement secured for $40 million.

  1 source·29/09, 11:02·sec.gov

• +4

  Company held Investor Day, showcasing potential growth.

  1 source·26/09, 20:08·sec.gov

• +8

  Harrow, Inc. plans to acquire Melt Pharmaceuticals.

  1 source·26/09, 11:08·sec.gov

• 0

  Harrow, Inc. changed its independent auditor.

  1 source·19/09, 20:08·sec.gov